Search

Search Constraints

You searched for: Author/Creator Aranda, Enrique

Search Results

1. A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). (December 2022)

2. Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. (November 2018)

3. First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD). (August 2017)

4. Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group. (April 2017)

5. Genetic variants in the renin–angiotensin system predict response to bevacizumab in cancer patients. (20th November 2015)

6. Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications. Issue 8 (August 2021)

7. Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes. Issue 4 (8th April 2021)

8. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Issue 10338 (14th May 2022)

10. Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial. (March 2021)